Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12 Week, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial for the Evaluation of the Efficacy and Safety of Tabetri on Osteoarthritis

NCT03757611 is registered in ClinicalTrials.gov with Jaseng Medical Foundation as lead sponsor.

NCT NCT03757611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03757611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12 Week, Multi-center, Randomized, Double-blind, Placebo-controlled Clinical Trial for the Evaluation of the Efficacy and Safety of Tabetri on Osteoarthritis
Lead sponsor
Jaseng Medical Foundation
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2017
Completion date
June 15, 2018
Enrollment
100 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis